Alterations identified by Titan-CNA in the 4q12 MCR covered recognized oncogenes and genes with known biological significance in glioma and glioblastoma, including PDGFRA, REST, and CLOCK9,23,24 (Figure 2F box). This evidence concerns the gene PDGFRA and glioma.